(941) 957-0200 * Disclaimer - Outcomes depend on multiple factors including adherence to physician-directed nutrition, physical activity, medical supervision, and individual health status
The use of pharmacokinetic and pharmacodynamic data in the assessment of drug safety in early drug development
People who have filed lawsuits have cited the following issues after taking Ozempic and other GLP-1 drugs: Acute kidney injury Stomach paralysis Bowel obstructions Chronic vomiting Ileus Pulmonary aspiration Biliary diseases Constipation Diarrhea Gallbladder inflammation Gallstones Gastroparesis Hypoglycemia Liver or kidney failure Nausea Hair loss Pancreatitis Vision loss Long-term use or high dosage of Ozempic (especially when used for weight loss) may increase the risk of gallbladder problems
Its all about the market forces
Also, use the transition period to assess how your claims will be submitted for billing to ensure services (e.g., telehealth services) meet the necessary requirements
The post says most clinical data spans two to three years, drawn primarily from the SUSTAIN clinical trial series and post-marketing pharmacovigilance
